Alert #1: Drugmaker Alkermes switches from ESP to Truzo, plus requires data submission On Friday, November 14, the drug manufacturer Alkermes sent a notification to covered entities informing them of …
Year: 2025
Bausch Health Exiting Medicaid Drug Rebate and 340B Programs
On October 1, 2025, Bausch Health voluntarily withdrew from both the 340B Drug Pricing Program and the Medicaid Drug Rebate Program (MDRP). This action applies to 12 labeler codes and …
Changes to RHC and FQHC Vaccine Reimbursement
Effective January 1, 2025, Medicare will begin reimbursing hepatitis B vaccines in the same manner as other Part B preventive vaccines. Effective July 1, 2025, Medicare will implement claim-based payments …
Draffin Tucker Announces July 2025 Promotions
Draffin Tucker Announces July 2025 Promotions ALBANY, GA – Draffin Tucker is proud to recognize five team members for their recent promotions, effective July 1, 2025. These professionals have demonstrated consistent …
Draffin Tucker Welcomes New Team Members
Draffin Tucker Welcomes New Team Members ALBANY, GA — Draffin Tucker, a full-service CPA and advisory firm, is proud to welcome several new professionals to its growing team. These new …
BPHC Issues Updated NOA Terms for 330(e) Grantees
HRSA announced new requirements related to the April 15th 2025 Executive Order. Health centers participating in 340B and receiving 330(e) funding must provide insulins and injectable epinephrine at 340B discounts …
Draffin Tucker Welcomes Jake Kitchens and Ben Glass Into Firm Partnership
Draffin Tucker Welcomes Jake Kitchens and Ben Glass Into Firm Partnership Albany, GA. – Draffin Tucker is pleased to announce the admission of Jake Kitchens and Ben Glass as Partners …
Jeff Askey’s Contributions: Key Insights on THCGME Funding
Draffin Tucker is proud to recognize partner Jeff Askey’s critical contributions to a groundbreaking study on the Teaching Health Center Graduate Medical Education (THCGME) program. Understanding the THCGME Program The …